Tuesday, August 30, 2016

UPDATE 1-Rigel's bleeding disorder drug clears first of two key trials

Aug 30 (Reuters) - Rigel Pharmaceuticals Inc said

its experimental drug to treat a bleeding disorder met its main

goal in the first of two late-stage trials, sending its shares

up 12 pct in...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)